Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis
y li qu trnh lo ha, ngn chn np nhn, da chy x, i mi
Eli Lilly (LLY $774.23 NYSE) Strong GLP-1 Fueled Growth COMPANY OVERVIEW Headquartered in Indianapolis, Eli Lilly (NYSE: LLY) is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines aimed at treating a variety of diseases across diabetes, oncology, immunology, and neuroscience
According to leading obesity researchers, GLP-1 medications have been shown in numerous studies to support significant, sustainable weight loss and long-term health improvements. Helps regulate appetite and hunger signals Improves metabolic health Get ready to watch your weight drop Includes telehealth consultations